Vaccines for emergency use – WHO Press Conference (15 February 2021)

About This Source - United Nations

The United Nations (UN) was established after World War II with the aim of preventing future wars. The organization is financed by assessed and voluntary contributions from its member states.

The UN’s chief administrative officer is the Secretary-General, currently Portuguese politician and diplomat António Guterres, who began his five year-term on 1 January 2017.

 

Recent from United Nations:

  • Mother Earth Day 2021 – António Guterres (UN Secretary-General)
  • UN launches appeal for Saint Vincent & the Grenadines
  • State of the Global Climate Report – World Meteorological Organization
  • United Nations published this video item, entitled “Vaccines for emergency use – WHO Press Conference (15 February 2021)” – below is their description.

    WHO today listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be rolled out globally through COVAX. The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.

    WHO’s Emergency Use Listing assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX Facility vaccine supply. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines.

    The WHO EUL process can be carried out quickly when vaccine developers submit the full data required by WHO in a timely manner. Once those data are submitted, WHO can rapidly assemble its evaluation team and regulators from around the world to assess the information and, when necessary, carry out inspections of manufacturing sites.

    In the case of the two AstraZeneca/Oxford vaccines, WHO assessed the quality, safety and efficacy data, risk management plans and programmatic suitability, such as cold chain requirements. The process took under four weeks.

    The vaccine was reviewed on 8 February by WHO’s Strategic Advisory Group of Experts on Immunization, which makes recommendations for vaccines’ use in populations (i.e. recommended age groups, intervals between shots, advice for specific groups such as pregnant and lactating women). The SAGE recommended the vaccine for all age groups 18 and above.

    The AstraZeneca/Oxford product is a viral vectored vaccine called ChAdOx1-S [recombinant]. It is being produced at several manufacturing sites, as well as in the Republic of Korea and India. ChAdOx1-S has been found to have 63.09% efficacy and is suitable for low- and middle-income countries due to easy storage requirements.

    Deusdedit Mubangizi, Head of WHO’s Prequalification Unit told reporters, “today is a great day, especially for the COVAX.”

    He continued, “we started assessing these two vaccines hardly four weeks ago. But when you look at the map that has been shown in this various fora where you have continents that have access to vaccines and then other countries that don’t have, I think,any movement that increases capacity on the manufacturing and supply of vaccine is a great milestone for this world.”

    The emergency use listing procedure assesses the suitability of novel health products during public health emergencies. The objective is to make medicines, vaccines and diagnostics available as rapidly as possible to address the emergency, while adhering to stringent criteria of safety, efficacy and quality. The assessment weighs the threat posed by the emergency as well as the benefit that would accrue from the use of the product against any potential risks.

    The EUL pathway involves a rigorous assessment of late phase II and phase III clinical trial data as well as substantial additional data on safety, efficacy, quality and a risk management plan. These data are reviewed by independent experts and WHO teams who consider the current body of evidence on the vaccine under consideration, the plans for monitoring its use, and plans for further studies.

    As part of the EUL process, the company producing the vaccine must commit to continue to generate data to enable full licensure and WHO prequalification of the vaccine. The WHO prequalification process will assess additional clinical data generated from vaccine trials and deployment on a rolling basis to ensure the vaccine meets the necessary standards of quality, safety and efficacy for broader availability.

    WHO also listed the Pfizer/BioNTech vaccine for emergency use on 31 December 2020.

    WHO’s Dr Mike Ryan also briefed the reporters. He said, “this mission was envisaged as a collaborative effort under the under the World Health Assembly resolution, where obviously working with China, a sovereign state, a member state of WHO, to better understand the origins of the virus so as to learn lessons for the future.”

    He continued, “it was not as such an investigation of supposed wrongdoing or referring to any nonexistent investigatory powers that WHO might have. WHO does not possess the mandate to enter uninvited to any nation state.”

    Dr Tedros also said, “many times I hear that this is a WHO study or investigation. It’s not. It’s an independent study, a study which is composed of independent individuals from 10 institutions. And WHO’s role here is coordination and that’s what we should take into consideration too.”

    On Ebola, Dr Tedros said, on Sunday, “authorities in Guinea declared a separate outbreak of Ebola in the town of Gouecke, in the southeast of the country.”

    Dr Tedros continued, “as you remember, Guinea was one of the three countries affected by the West Africa Ebola outbreak of 2014 to 2016, the largest Ebola outbreak on record. The outbreaks in Guinea and DRC are completely unrelated, but we face similar challenges in both.”

    United Nations YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: AstraZeneca

    AstraZeneca plc/AB (LON: AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Södertälje, Sweden. Its R&D is concentrated in Cambridge in United Kingdom, Södertälje in Sweden, and Maryland and Toronto in North America.

    3 Recent Items: AstraZeneca

  • Mexican president gets first dose of AstraZeneca vaccine
  • Tony Blair: UK should publish COVID vaccine data to ‘restore credibility’
  • Victoria’s mass vaccination hubs open up | 9 News Australia
  • In This Story: BioNTech

    BioNTech SE (NASDAQ: BNTX) is a German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases.

    5 Recent Items: BioNTech

  • Can Covid vaccines be mixed? | ITV News
  • U.S. Recommends ‘Pause’ for Johnson & Johnson Vaccine Over Blood Clot Reports
  • J&J Vaccine: Six Cases of Rare Blood Clot Disorder Found in U.S.
  • Lockdown, not vaccines behind drop in UK COVID-19 deaths: Boris Johnson
  • South African Covid variant may evade the Pfizer vaccine, according to Israeli study
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • FDA completes Emergent Biosolutions factory inspection, orders fixes
  • LIVE: People protest in Berlin as parliament votes on new COVID restrictions
  • Ontario premier isolating after COVID-19 exposure risk
  • WATCH LIVE: Indian Migrant Workers Rush Home Amid New Delhi Lockdown | Top News
  • Slideshow: Israel drops outdoor mask order
  • In This Story: Guinea

    Guinea is a country in West Africa, bordered on the west by the Atlantic Ocean. Formerly known as French Guinea (French: Guinée française), the modern country is sometimes referred to as Guinea-Conakry to distinguish it from other countries with “Guinea” in the name.

    It’s known for the Mount Nimba Strict Nature Reserve, in the southeast. The reserve protects a forested mountain range rich in native plants and animals, including chimpanzees and the viviparous toad. On the coast, the capital city, Conakry, is home to the modern Grand Mosque and the National Museum.

    2 Recent Items: Guinea

  • WHO COVID-19 Update (16 April 2021)
  • Chinese President Xi Jinping receives credentials of 29 ambassadors
  • In This Story: India

    India, officially the Republic of India, is a country in South Asia. It is the second-most populous country, the seventh-largest country by land area, and the most populous democracy in the world. New Delhi is the capital.

    It has an exceptionally diverse population, with Hindus, Muslims, Christians, Sikhs, Buddhists, Jains and other religions speaking over 21 recognised languages.

    2 Recent Items: India

  • WATCH LIVE: Indian Migrant Workers Rush Home Amid New Delhi Lockdown | Top News
  • Medical oxygen supplies run low in India
  • In This Story: Pfizer

    Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

    5 Recent Items: Pfizer

  • Coronavirus: Brisbane man suffers blood clot after Pfizer vaccine | 9 News Australia
  • Victoria’s mass vaccination hubs open up | 9 News Australia
  • Pfizer fears after Queensland cop gets hospitalised after jab | 7NEWS
  • Australia to produce Pfizer and Moderna vaccines, George Floyd’s family speak out | 9News Australia
  • Why has Pfizer stock remained flat throughout the pandemic? #AskHalftime
  • Leave a Comment